SENATE BILL REPORT
This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent.
As of February 10, 2020
Title: An act relating to reducing barriers to patient care through appropriate use of prior authorization and adoption of appropriate use criteria.
Brief Description: Adopting prior authorization and appropriate use criteria in patient care.
Sponsors: Senators Frockt, O'Ban, Dhingra, Becker, Kuderer, Rivers, Lovelett, Wellman, Pedersen, Nguyen, Darneille, Hasegawa, McCoy, Wilson, C., Das, Conway and Saldaña.
Committee Activity: Health & Long Term Care: 1/31/20.
SENATE COMMITTEE ON HEALTH & LONG TERM CARE
Staff: Evan Klein (786-7483)
Background: Prior Authorization. Prior authorization is a requirement that a health care provider obtain approval from a patient's insurance plan to prescribe a specific medication or treatment. Health carriers may impose different prior authorization standards and criteria for a covered service among tiers of contracting providers.
In 2018, the Legislature prohibited health carriers from requiring prior authorization for initial evaluation and management visits, and up to six consecutive treatment visits in a new episode of care of chiropractic, physical therapy, occupational therapy, east Asian medicine, massage therapy, and speech and hearing therapies that meet the standards of medical necessity and are subject to quantitative treatment limits of the health plan.
Dr. Robert Bree Collaborative. The Dr. Robert Bree Collaborative (Collaborative) is an organization funded by the Health Care Authority (HCA) which convenes public and private stakeholders to improve the quality, health outcomes, and cost effectiveness of health care in Washington State. The Collaborative identifies health care services that have substantial variations in practice patterns or high utilization trends and investigates evidence-based practices that will improve quality and reduce variation in the use of the services. Members of the Collaborative are appointed by the Governor. The Collaborative has published reports on topics such as accountable payment models, addiction and dependence treatment, cardiovascular health, obstetrics, potentially avoidable hospital readmissions, and pediatric psychotropic use.
All state purchased health care programs must implement evidence-based best practice guidelines or protocols developed by the Collaborative after the HCA administrator, in consultation with participating agencies, has affirmatively reviewed and endorsed the recommendations. Beginning in 2021, qualified health plans contracted by HCA to be offered on the individual market, will be required to incorporate recommendations of the Collaborative.
Summary of Bill: By October 1, 2020, for health plans issued by a carrier, a carrier must report the following information to the commissioner for the 2019 plan year:
a list of all covered services subject to prior authorization;
The total number of prior authorization requests for each service;
the number and percentage of requests approved;
the number of requests initially denied and then appealed, including overturn rates in excess of 75 percent;
the number and percentage of claims denied due to absence of an approved prior authorization; and
the average and median determination response time for requests.
By October 1, 2021 and annually thereafter, for health plans issued by a carrier, a carrier must report to the commissioner any new or adjusted prior authorization requirements, within 90 days of imposing the new requirement.
A prior authorization work group (work group) is created to enhance the understanding of prior authorization in Washington. The work group must be hosted and staffed by the Collaborative. The Governor must appoint 15 members to the work group comprised of representatives from providers, hospitals, clinics, carriers, and the HCA.
By January 1, 2021 and annually thereafter, the work group must select at least five medical or surgical services subject to prior authorization by insurance carriers for review. The work group must conduct its review and develop recommendations by December 31st. In 2021, the work group must review as one of the services selected, noninvasive cardiac diagnostic imaging procedures. The work group must prioritize other services for review based on:
the volume of the service;
indications based on medical literature that prior authorization is not appropriate for the service;
the potential for negative impact on patient care caused by prior authorization delays; and
input from providers, facilities, carriers, and purchasers.
For each service selected, the work group must assess:
Whether the utilization and approval patterns and literature justify the use of prior authorization. If not, the work group must recommend no prior authorization for the service.
Whether adoption of uniform appropriate use criteria or evidence-based criteria confirmed through a clinical decision support mechanism for the service in lieu of prior authorization is appropriate. If so, the work group must identify and select or develop appropriate use criteria.
Whether an appropriate federal policy or initiative exists for the service. If so, the work group recommendations should align.
The services as provided to adults and pediatric patients, and must provide separate recommendations where appropriate.
The work group must review and make updates to the recommendations as necessary.
The work group must establish subcommittees, comprised of practicing clinicians with relevant expertise, to focus on specific services selected for review. Each subcommittee must include at least two members of the specialty or subspecialty most experienced for the review. Each subcommittee must make recommendations to the work group.
The commissioner must:
compile and provide data collected to the work group;
develop standardized reports of aggregated and deidentified data and make the reports available upon request to interested parties;
post recommendations of the work group on the commissioner's website;
adopt rules incorporating the work group recommendations; and
update the rules based on changes or additions to the recommendations of the work group.
The commissioner may only decline to adopt a recommendation of the work group if experts in the field offer clear evidence that the standards conflicts with relevant evidence-based guidelines.
The commissioner may adopt rules, but must consult stakeholders, including carriers, health care practitioners, health care facilities, and patients.
Carriers, Public Employee Benefits Board and School Employees Benefits Board health plans, and Medicaid managed care plans must adopt the prior authorization standards required by the commissioner in rule.
Fiscal Note: Requested on January 24, 2020.
Creates Committee/Commission/Task Force that includes Legislative members: No.
Effective Date: Ninety days after adjournment of session in which bill is passed.
Staff Summary of Public Testimony: PRO: It is time for Washington, in its health care delivery system, to take a hard look at the prior authorization process. This process impacts physicians and patients. The prior authorization system is a burden and overly complex. Providers eventually get procedures approved, but have to call health plans multiple times to do so. We do not know the rates at which health plans are denying procedures. A key part of the bill is transparency for providers. The process is also terrible for patients. Patients do not have time to fight insurance to get their services approved. There may be times where prior authorization controls are appropriate. Medicare is moving towards ensuring routine procedures can be done without prior authorization. The health care system is far too administratively complex. The Medicaid Managed Care Organizations have made notes that they want to standardize prior authorization processes, but it is unclear whether they have implemented standard practices. After initial denials of a prior authorization, 92 percent or more of the time, the service is approved. Over $266 billion is wasted in the United State health care system due to administrative costs. Prior authorization has led to serious adverse events and even to patients abandoning treatment. This is not an attempt to ban prior authorization all-together. When used appropriately, prior authorization is a good tool for cost containment. When over-used and not standardized, prior authorization leads to issues for physicians and patients. Use of prior authorization has increased year over year. The benefit of standardization is that providers can build uniform criteria in their practices, reducing patient delays and expediting care.
CON: Health plans use prior authorization for the same reasons that public entities and other purchasers use these tools. These are used to address gaps between evidence based practices and the care that is delivered to patients, to avoid overuse and misuse of treatments. Prior authorization ensures prescriptions are not co-prescribed, it ensures that providers have the appropriate training to make the appropriate diagnosis, and to ensure there is no overuse, misuse, or underuse of services. Prior authorization ensures that services are delivered timely in a way that reflects appropriate practice patterns. Provider practice patterns that lack accountability are the third leading cause of death in the United States. Patients are being overprescribed opioids and other psychotropic drugs. The Legislature has enacted a series of prior authorization requirements in recent years. This bill has a breathtaking delegation of authority to an entity that does not have rulemaking authority and is not subject to the Administrative Procedures Act. The OIC just implemented the third phase of prior authorization rulemaking that includes an online portal to help standardize practices. Some of the information required to be produced by this report may be information that is not currently tracked, or based on services that are not even provided. An unelected board has never been able to require an agency to develop a rule, and would be prohibited by the administrative procedures act's requirement to allow public comment in developing a rule. Health plans have panels of providers that are consulted for prior authorization decisions.
OTHER: The OIC did a data request for health plans to compare how prior authorization is treated for mental health services and medical services. The request uncovered tens of thousands of pages of prior authorization criteria from the health plans. There is a desire to focus the bill on the top prior authorization criteria for review first. There is a desire to refine the rulemaking proposal in the bill, but there is definitely work needed around prior authorization and utilization review. The Health Care Authority has concerns associated with the impact of the legislation on Medicaid. Prior authorization certainly creates burdens for patients and providers. However, the implementation of this bill might violate certain federal requirements. Medicaid must be the sole decision maker for how money is spent under the program, and it is unclear whether the work group in the bill would compromise this federal funding. The hope is also to avoid reinventing the wheel, and to incorporate prior authorization recommendations already being developed at the federal level.
Persons Testifying: PRO: Senator David Frockt, Prime Sponsor; Sean Graham, Washington State Medical Association; James Hudson, Woodcreek Provider Services; Eugene Yang, MD, UW Medicine; Abby Moore, Washington Council for Behavioral Health; Erin Dziedzic, Bleeding Disorder Foundation of Washington and Foundations for Healthy Generations; Christine Palermo, Virginia Mason Medical Center; Diane Pirak, CHI Franciscan Health; Lisa Thatcher, Washington State Hospital Association. CON: Chris Bandoli, Association of Washington Healthcare Plans; Mel Sorensen, America's Health Insurance Plans. OTHER: Emily Transue, Health Care Authority; Lonnie Johns-Brown, Office of the Insurance Commissioner; Kate White Tudor, Center for Diagnostic Imaging.
Persons Signed In To Testify But Not Testifying: No one.